The National Times - Netflix film probes conviction of UK baby killer nurse

Netflix film probes conviction of UK baby killer nurse


Netflix film probes conviction of UK baby killer nurse
Netflix film probes conviction of UK baby killer nurse / Photo: © Cheshire Constabulary/AFP

A Netflix documentary released Wednesday about a former UK nurse jailed for life for murdering seven babies is taking a fresh look at the puzzling case of the prolific child killer.

Change text size:

Lucy Letby, 36, from Hereford, western England, was charged in 2020 following a string of deaths at a hospital's neo-natal unit.

But she has always maintained her innocence and a panel of international experts has since argued her conviction was wrong.

Her case shocked the nation during lengthy trials in 2023 and 2024, after which she was convicted and jailed for life for murdering seven babies and attempting to murder seven more.

Her young victims were either sick or born prematurely, and she was accused of injecting them with air, overfeeding them milk and poisoning them with insulin.

Ahead of the release of "The Investigation Of Lucy Letby", the former nurse's parents called the film "a complete invasion of privacy" for its use of previously unseen police bodycam footage of their daughter being arrested at their family home, The Sunday Times reported.

In a statement after watching the film's trailer, John and Susan Letby said they did not plan to watch the documentary.

"It would likely kill us if we did," they said.

"The previous programmes made about Lucy, including Panorama and the almost nightly news showing her being brought out handcuffed in a blue tracksuit are heartbreaking for us," they said.

"However, this Netflix documentary is on another level. We had no idea they were using footage in our house."

The film opens with the scene they refer to, of Letby's arrest in June 2019.

Police enter her bedroom and she is seen sitting up in bed, in pyjamas, appearing confused, as police say they are arresting her for murder. She is then taken away in her dressing gown.

The 90-minute film does not claim to be exhaustive, but aims to offer the public the perspectives of both sides of a case that continues to prompt questions and accusations of a miscarriage of justice.

It highlights unsettling elements, such as Letby responding "no comment" to police questions while in custody, and excerpts from her diary where dates coinciding with the babies' deaths are marked with an asterisk.

- 'Wrong person?' -

Conversely, the film also includes testimony from Canadian physician Shoo Lee, who challenged the expert evidence presented at trial. It ends with that of John Gibbs, a former pediatrician at the hospital where Letby worked.

"I live with two guilts," he says.

"Guilt that we let the babies down, and tiny, tiny, tiny guilt: did we get the wrong person? You know, just in case: a miscarriage of justice. I don't think there was a miscarriage of justice, but you worry that no one actually saw her do it."

Letby was twice denied permission to appeal against her convictions in 2024.

The Criminal Cases Review Commission (CCRC), which investigates potential miscarriages of justice, is considering evidence presented on her behalf from an international panel of medics who claim poor medical care and natural causes were the reasons for the babies.

Inquests into the deaths of six babies who Letby was convicted of murdering have been opened and then adjourned to May 5.

The inquest into the seventh baby did not determine the cause of death.

The senior coroner at the inquests adjourned them until September pending the outcome of a public inquiry into the Letby case which is due to be published this year.

Health Minister Wes Streeting told LBC radio Wednesday her fate should be decided by the courts and not campaigners "unless and until there is a judicial process that says that the court has got it wrong".

F.Adams--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: